Doximity, Inc. $DOCS Shares Purchased by Whittier Trust Co.

Whittier Trust Co. raised its holdings in Doximity, Inc. (NYSE:DOCS) by 84,669.6% in the 1st quarter, Holdings Channel reports. The institutional investor owned 183,950 shares of the company’s stock after acquiring an additional 183,733 shares during the period. Whittier Trust Co.’s holdings in Doximity were worth $4,242,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Doximity by 0.5% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 38,978 shares of the company’s stock worth $2,262,000 after acquiring an additional 210 shares during the period. BOKF NA increased its position in Doximity by 5.3% during the third quarter. BOKF NA now owns 5,356 shares of the company’s stock worth $392,000 after purchasing an additional 269 shares during the last quarter. Northwestern Mutual Investment Management Company LLC raised its stake in Doximity by 1.1% during the fourth quarter. Northwestern Mutual Investment Management Company LLC now owns 30,736 shares of the company’s stock worth $1,361,000 after purchasing an additional 333 shares during the period. Lifestyle Asset Management Inc. boosted its holdings in shares of Doximity by 5.9% in the 4th quarter. Lifestyle Asset Management Inc. now owns 7,083 shares of the company’s stock valued at $314,000 after purchasing an additional 396 shares during the last quarter. Finally, Northwestern Mutual Wealth Management Co. grew its stake in shares of Doximity by 99.5% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 796 shares of the company’s stock valued at $35,000 after buying an additional 397 shares during the period. Institutional investors and hedge funds own 87.19% of the company’s stock.

Insider Activity

In other Doximity news, insider Siddharth Sitaram sold 2,444 shares of the business’s stock in a transaction dated Monday, June 8th. The stock was sold at an average price of $20.41, for a total transaction of $49,882.04. Following the transaction, the insider owned 90,706 shares in the company, valued at $1,851,309.46. The trade was a 2.62% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Kira Scherer Wampler sold 9,000 shares of the company’s stock in a transaction dated Thursday, May 7th. The stock was sold at an average price of $26.06, for a total value of $234,540.00. Following the completion of the sale, the director directly owned 19,839 shares of the company’s stock, valued at $517,004.34. The trade was a 31.21% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 16,180 shares of company stock worth $395,110 over the last three months. 31.30% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

DOCS has been the subject of a number of research analyst reports. Canaccord Genuity Group dropped their price objective on Doximity from $34.00 to $30.00 and set a “buy” rating for the company in a report on Thursday, May 14th. JPMorgan Chase & Co. reduced their target price on Doximity from $33.00 to $28.00 and set a “neutral” rating on the stock in a report on Thursday, May 14th. Weiss Ratings lowered Doximity from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Friday, May 15th. Robert W. Baird restated a “neutral” rating and issued a $18.00 price objective (down from $40.00) on shares of Doximity in a report on Thursday, May 14th. Finally, Morgan Stanley cut their price objective on Doximity from $49.00 to $35.00 and set an “overweight” rating on the stock in a report on Thursday, May 14th. Two investment analysts have rated the stock with a Strong Buy rating, six have given a Buy rating, twelve have given a Hold rating and four have issued a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $29.33.

Doximity Stock Performance

Shares of NYSE:DOCS traded up $0.08 during midday trading on Tuesday, hitting $22.94. 510,151 shares of the company’s stock traded hands, compared to its average volume of 3,792,135. The firm’s fifty day moving average price is $21.62 and its two-hundred day moving average price is $28.09. Doximity, Inc. has a twelve month low of $17.15 and a twelve month high of $76.51. The company has a market cap of $4.20 billion, a PE ratio of 23.07, a P/E/G ratio of 6.79 and a beta of 1.30.

About Doximity

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.